RBFOX3 and urinary bladder carcinoma: In a case–control study involving 580 patients with bladder cancer and 1,101 control subjects, the single-nucleotide polymorphism rs978416 G>A in RBFOX3 was potentially associated with bladder cancer predisposition in the Chinese population (106), indicating its potential as a novel biomarker of bladder cancer risk.